Literature DB >> 3674642

Histochemical study of posterior cricoarytenoid muscle reinnervation by a nerve-muscle pedicle in the cat.

J J Fata1, L T Malmgren, R R Gacek, R Dum, P Woo.   

Abstract

Reinnervation of the posterior cricoarytenoid (PCA) muscle with a nerve-muscle pedicle (NMP) has been proposed for patients with bilateral abductor vocal cord paralysis. Since its success has been controversial, a glycogen depletion histochemical technique was used to examine reinnervation. An ansa cervicalis NMP was implanted into the denervated PCA in nine cats. Eight months later, vocal cord activity was evaluated. The NMP nerve was stimulated extensively in seven cats (experimental group). Optical densities of NMP-supplied PCA muscle fibers from experimental and control groups were compared to detect differences in glycogen content. The results demonstrated quantitative evidence of reinnervation in two experimental animals. Electrical stimulation of the NMP produced abduction in one of these two animals, but was never observed during spontaneous respiration or airway occlusion. These observations indicate that reinnervation can occur but abduction requires electrical stimulation. The NMP technique may be more successful with an electrical pacer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674642     DOI: 10.1177/000348948709600501

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Reinnervation of denervated muscle by implantation of nerve-muscle-endplate band graft to the native motor zone of the target muscle.

Authors:  Liancai Mu; Stanislaw Sobotka; Jingming Chen; Themba Nyirenda
Journal:  Brain Behav       Date:  2017-05-03       Impact factor: 2.708

2.  Reinnervation of bilateral posterior cricoarytenoid muscles using the left phrenic nerve in patients with bilateral vocal fold paralysis.

Authors:  Meng Li; Shicai Chen; Hongliang Zheng; Donghui Chen; Minhui Zhu; Wei Wang; Fei Liu; Caiyun Zhang
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.